1. Small lymphocytic lymphoma presenting as bulky renal incidentaloma

   • Kazuharu Kamachi
   • Kensuke Kojima
   • Shinya Kimura

   Images in Hematology 14 June 2014 Pages: 107 - 108

   

2. Relapse of acute megakaryocytic leukemia as hepatic myeloid sarcoma after allogeneic haploidentical hematopoietic stem cell transplantation

   • Toshihiko Imamura
   • Yoshihiro Nitta
   • Hajime Hosoi

   Images in Hematology 11 June 2014 Pages: 109 - 110

   

3. No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse

   • Eirunn Knudsen
   • Harald Carlsen
   • Per Ole Iversen

   Original Article 24 May 2014 Pages: 111 - 118

   

4. Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes

   • Laura G. Stoudenmire
   • Christina E. DeRemer
   • Hazem Elewa

   Original Article 21 June 2014 Pages: 119 - 124

   

5. Diagnosis of overt disseminated intravascular coagulation in critically Ill adults by Sonoclot coagulation analysis

   • Peng Wan
   • Hua-Sheng Tong
   • Lei Su

   Original Article 31 May 2014 Pages: 125 - 131

   

6. Prognostic discrimination for early chronic phase chronic myeloid leukemia in imatinib era: comparison of Sokal, Euro, and EUTOS scores in Korean population

   • Seung-Ah Yahng
   • Eun-Jung Jang
   • Dong-Wook Kim

   Original Article 31 May 2014 Pages: 132 - 140

   

7. Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients

   • Soo-Jeong Kim
   • June-Won Cheong
   • The Korean Society of Hematology AML/MDS Working Party

   Original Article 05 July 2014 Pages: 141 - 151

   

8. Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma

   • Kotaro Miyao
   • Reona Sakemura
   • Masashi Sawa

   Original Article 20 June 2014 Pages: 152 - 158

   

9. Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients

   • Shuichiro Takashima
   • Toshihiro Miyamoto
   • Koichi Akashi

   Original Article 14 June 2014 Pages: 159 - 164

10. Homing of cytokine-induced killer cells during the treatment of acute promyelocytic leukemia

    • Hong Wang
    • Fenglin Cao
    • Jin Zhou

    Original Article 15 June 2014 Pages: 165 - 170

    

11. Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol

    • Hideki Nakayama
    • Ken Tabuchi
    • Souichi Adachi

    Original Article 25 June 2014 Pages: 171 - 179

    

12. Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children’s Cancer Study Group (TCCSG) clinical trials

    • Motohiro Kato
    • Atsushi Manabe
    • Akira Ohara

    Original Article 18 June 2014 Pages: 180 - 187

    

13. Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus

    • Seung Beom Han
    • E Young Bae
    • Hack-Ki Kim

    Original Article 01 July 2014 Pages: 188 - 199

    

14. A complex genomic abnormality found in a patient with antithrombin deficiency and autoimmune disease-like symptoms

    • Io Kato
    • Yuki Takagi
    • Tetsuhito Kojima

    Case Report 03 June 2014 Pages: 200 - 205

    

15. Serial monitoring of Mucorales DNA load in serum samples of a patient with disseminated mucormycosis after allogeneic bone marrow transplantation

    • Tomonari Shigemura
    • Yozo Nakazawa
    • Kenichi Koike

    Case Report 22 May 2014 Pages: 206 - 209